Thermo Fisher Services Granted Access to ATUM's Gene Design Platform

Formerly known as DNA2.0, ATUM has announced it has signed a patent licensing agreement granting Thermo Fisher Scientific access to its novel gene design platform.

Source: Pharmaceutical Technology - May 18, 2017 Category: Pharmaceuticals Source Type: news